DEA Allows Drug Company to Import Cannabis

A drug delivery and technology company has received approval from the US Drug Enforcement Administration to import marijuana for research.

Catalent, a New Jersey-based drug development and technology company, applied with the DEA in August to allow its Kansas City, Mo., facility to import cannabis. The DEA approved the request in early December, according to a Federal Notice.

According to the notice, Catalent will “import finished pharmaceutical products containing cannabis extracts in…

CONTINUE READING: Click Here to Continue Reading Article …